comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 19:20:39 - browse：6

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Hilary may become 1st tropical storm to make landfall in California in 84 years

knowledge

WSS

Asbestos, a deadly carcinogen, banned by EPA

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Colonoscopy prep: Liquid

The pain doctors face in trying to build their families

Nurses recount patients attacks

New definition of a human embryo proposed amid rapid advances

focus

comprehensive

hotspot

Guidelines to prevent youth baseball injuries need more muscle

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Peter Hotez and the public health issue of online harassment

Congress must give Medicare recipients genetic counseling access

New air purifier tech could be key to improving indoor air quality

Gene editing the human germline: What are the risks?

In age of alternative facts, a scholarly course on calling out crap

App could help diagnose ear infections more accurately — and at home

State Dept. review finds Biden bears some blame for Afghanistan failures

As Maui death toll rises, number of missing remains unclear

entertainment

UnitedHealth increases loan offers after Change Healthcare outage

Stop the failed accountable care organization experiment

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Evacuations in place as 3 wildfires burn in eastern Washington state

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Living with Hashimoto's and celiac disease, and med school, too

Wikipedia

hotspot

knowledge

hotspot